Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2023

17-03-2023 | Original Article

Magnetic Resonance Liver Iron Concentration Can Guide Venesection Decision-Making in Hyperferritinemia

Authors: Meha Bhuva, Ilse Patterson, Edmund M. Godfrey, David J. Bowden, William J. H. Griffiths

Published in: Digestive Diseases and Sciences | Issue 6/2023

Login to get access

Abstract

Background

The clinical benefit of venesection in suspected iron overload can be unclear and serum ferritin may overestimate the degree of iron overload.

Aims

To help inform practice, we examined magnetic resonance liver iron concentration (MRLIC) in a cohort investigated for haemochromatosis.

Methods

One hundred and six subjects with suspected haemochromatosis underwent HFE genotyping and MRLIC with time-matched serum ferritin and transferrin saturation values. For those treated with venesection, volume of blood removed was calculated as a measure of iron overload.

Results

Forty-seven C282Y homozygotes had median ferritin 937 µg/l and MRLIC 4.83 mg/g; MRLIC was significantly higher vs non-homozygotes for any given ferritin concentration. No significant difference in MRLIC was observed between homozygotes with and without additional risk factors for hyperferritinemia. Thirty-three compound heterozygotes (C282Y/H63D) had median ferritin 767 µg/l and MRLIC 2.58 mg/g; ferritin < 750 µg/l showed 100% specificity for lack of significant iron overload (< 3.2 mg/g). 79% of C282Y/H63D had additional risk factors—mean MRLIC was significantly lower in this sub-group (2.4 mg/g vs 3.23 mg/g). 26 C282Y heterozygous or wild-type had median ferritin 1226 µg/l and MRLIC 2.13 mg/g; 69% with additional risk factors had significantly higher ferritin concentrations (with comparable MRLIC) and ferritin < 1000 µg/l showed 100% specificity for lack of significant iron overload. In 31 patients (26 homozygotes, 5 C282Y/H63D) venesected to ferritin < 100 µg/l, MRLIC and total venesection volume correlated strongly (r = 0.749), unlike MRLIC and serum ferritin.

Conclusion

MRLIC is an accurate marker of iron overload in haemochromatosis. We propose serum ferritin thresholds in non-homozygotes which, if validated, could tailor cost-effective use of MRLIC in venesection decision-making.
Literature
1.
go back to reference European Association for the Study of the Liver. EASL clinical practice guidelines on haemochromatosis. J Hepatol. 2022;7:479–502. European Association for the Study of the Liver. EASL clinical practice guidelines on haemochromatosis. J Hepatol. 2022;7:479–502.
3.
go back to reference Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of haemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011;54:328–343.CrossRefPubMed Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of haemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011;54:328–343.CrossRefPubMed
5.
go back to reference Deugnier Y, Bardou-Jacquet E, Laine F. Dysmetabolic iron overload syndrome. Presse Medicale 2017;46:e306-311.CrossRefPubMed Deugnier Y, Bardou-Jacquet E, Laine F. Dysmetabolic iron overload syndrome. Presse Medicale 2017;46:e306-311.CrossRefPubMed
6.
go back to reference Le Gac G, Scotet V, Gourlaouen I et al. Prevalence of HFE-related haemochromatosis and secondary causes of hyperferritinaemia and their association with iron overload in 1059 French patients treated by venesection. Aliment Pharmacol Ther. 2022;55:1016–1027.CrossRefPubMed Le Gac G, Scotet V, Gourlaouen I et al. Prevalence of HFE-related haemochromatosis and secondary causes of hyperferritinaemia and their association with iron overload in 1059 French patients treated by venesection. Aliment Pharmacol Ther. 2022;55:1016–1027.CrossRefPubMed
7.
go back to reference Brittenham GM, Badman DG. Noninvasive measurement of iron: report of an NIDDK workshop. Blood 2003;101:15–19.CrossRefPubMed Brittenham GM, Badman DG. Noninvasive measurement of iron: report of an NIDDK workshop. Blood 2003;101:15–19.CrossRefPubMed
8.
go back to reference Wood JC, Zhang P, Rienhoff H, Abi-Saab W, Neufeld EJ. Liver MRI is more precise than liver biopsy for assessing total body iron balance: a comparison of MRI relaxometry with simulated liver biopsy results. Magn Reson Imaging 2015;33:761–767.CrossRefPubMed Wood JC, Zhang P, Rienhoff H, Abi-Saab W, Neufeld EJ. Liver MRI is more precise than liver biopsy for assessing total body iron balance: a comparison of MRI relaxometry with simulated liver biopsy results. Magn Reson Imaging 2015;33:761–767.CrossRefPubMed
9.
go back to reference Gandon Y, Olivie D, Guyader D et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363:357–362.CrossRefPubMed Gandon Y, Olivie D, Guyader D et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363:357–362.CrossRefPubMed
10.
go back to reference St Pierre TG, El-Beshlawy A, Elalfy M et al. Multicenter validation of spin-density projection-assisted R2-MRI for the non-invasive measurement of LIC. Magn Reson Med. 2014;71:2215–2223.CrossRefPubMed St Pierre TG, El-Beshlawy A, Elalfy M et al. Multicenter validation of spin-density projection-assisted R2-MRI for the non-invasive measurement of LIC. Magn Reson Med. 2014;71:2215–2223.CrossRefPubMed
11.
go back to reference D’Assignies G, Paisant A, Bardou-Jacquet E et al. Non-invasive measurement of liver iron concentration using 3-Tesla magnetic resonance imaging: validation against biopsy. Eur Radiol. 2017;28:2022–2030.CrossRefPubMed D’Assignies G, Paisant A, Bardou-Jacquet E et al. Non-invasive measurement of liver iron concentration using 3-Tesla magnetic resonance imaging: validation against biopsy. Eur Radiol. 2017;28:2022–2030.CrossRefPubMed
12.
go back to reference Wunderlich A, Cario H, Juchems M, Beer M, Schmidt S. Non-invasive MRI-based liver iron quantification: methodic approaches, practical applicability and significance. RoFo. 2016;188:1031–1036.CrossRefPubMed Wunderlich A, Cario H, Juchems M, Beer M, Schmidt S. Non-invasive MRI-based liver iron quantification: methodic approaches, practical applicability and significance. RoFo. 2016;188:1031–1036.CrossRefPubMed
13.
go back to reference Castiella A, Alústiza JM, Emparanza JI, Zapata EM, Costero B, Díez MI. Liver iron concentration by MRI: are recommended protocols accurate enough for clinical practice? Eur Radiol. 2011;21:137–141.CrossRefPubMed Castiella A, Alústiza JM, Emparanza JI, Zapata EM, Costero B, Díez MI. Liver iron concentration by MRI: are recommended protocols accurate enough for clinical practice? Eur Radiol. 2011;21:137–141.CrossRefPubMed
14.
go back to reference Sarigianni M, Liakos A, Vlachaki E et al. Accuracy of Magnetic Resonance Imaging in diagnosis of liver iron overload: a systematic review and meta-analysis. Clin Gastro Hepatol. 2015;13:55–63.CrossRef Sarigianni M, Liakos A, Vlachaki E et al. Accuracy of Magnetic Resonance Imaging in diagnosis of liver iron overload: a systematic review and meta-analysis. Clin Gastro Hepatol. 2015;13:55–63.CrossRef
15.
go back to reference Sirlin CB, Reeder SB. Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin. 2010;18:359–381.CrossRef Sirlin CB, Reeder SB. Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin. 2010;18:359–381.CrossRef
16.
go back to reference Alustiza JM, Artetxe J, Castiella A et al. MR quantification of hepatic iron concentration. Radiology 2004;230:479–484.CrossRefPubMed Alustiza JM, Artetxe J, Castiella A et al. MR quantification of hepatic iron concentration. Radiology 2004;230:479–484.CrossRefPubMed
17.
go back to reference St. Pierre TG, Clark PR, Chua-anusorn W et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855–861.CrossRefPubMed St. Pierre TG, Clark PR, Chua-anusorn W et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855–861.CrossRefPubMed
18.
go back to reference Wood JC, Enriquez C, Ghugre N et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005;106:1460–1465.CrossRefPubMedPubMedCentral Wood JC, Enriquez C, Ghugre N et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005;106:1460–1465.CrossRefPubMedPubMedCentral
19.
go back to reference Laine F, Ruivard M, Loustaud-Ratti V et al. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomised controlled study in 274 patients. Hepatology 2017;65:465–474.CrossRefPubMed Laine F, Ruivard M, Loustaud-Ratti V et al. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomised controlled study in 274 patients. Hepatology 2017;65:465–474.CrossRefPubMed
20.
go back to reference Cullis JO, Fitzsimons EJ, Griffiths WJH, Tsochatzis E, Thomas DW. Investigation and management of a raised serum ferritin. Br J Haematol. 2018;181:331–340.CrossRefPubMed Cullis JO, Fitzsimons EJ, Griffiths WJH, Tsochatzis E, Thomas DW. Investigation and management of a raised serum ferritin. Br J Haematol. 2018;181:331–340.CrossRefPubMed
Metadata
Title
Magnetic Resonance Liver Iron Concentration Can Guide Venesection Decision-Making in Hyperferritinemia
Authors
Meha Bhuva
Ilse Patterson
Edmund M. Godfrey
David J. Bowden
William J. H. Griffiths
Publication date
17-03-2023
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2023
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-07873-w

Other articles of this Issue 6/2023

Digestive Diseases and Sciences 6/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.